Less Ads, More Data, More Tools Register for FREE

Pin to quick picksTristel Regulatory News (TSTL)

Share Price Information for Tristel (TSTL)

Share Price is delayed by 15 minutes
Get Live Data
385.00    0.00 (0.00%)
Bid:
0.00
Ask:
0.00
Spread: 10.00 (2.632%)
Market Cap: £184.79m
TSTL Live PriceLast checked at - London Stock Exchange

Intraday Tristel Share Chart

Director/PDMR Shareholding

28 Jul 2023 08:28

RNS Number : 5571H
Tristel PLC
28 July 2023
 

 

Tristel plc

("Tristel" or the "Company")

 

Director/PDMR Shareholding

 

Tristel plc (AIM: TSTL), the manufacturer of infection prevention products, announces that on 27 July 2023, Paul Swinney, Chief Executive Officer, sold 100,000 ordinary shares of 1 penny each in the Company ("Ordinary Shares") at a price of 350 pence per Ordinary Share.

 

As a result, Paul Swinney's beneficial interest in the Company is 312,350 Ordinary Shares, representing 0.66 per cent. of the total issued share capital.

 

For further information please contact:

 

 

Tristel plc

Tel: 01638 721 500

Paul Swinney, Chief Executive Officer

Liz Dixon, Chief Financial Officer

 

Walbrook PR Ltd

Tel: 020 7933 8780 or tristel@walbrookpr.com

Paul McManus

Mob: 07980 541 893

Lianne Applegarth

Mob: 07584 391 303

finnCap

Tel: 020 7220 0500

Geoff Nash/ Charlie Beeson (Corporate Finance)

Alice Lane (ECM)

 

 

 

This announcement contains inside information for the purposes of Article 7 of the Market Abuse Regulation (EU) 596/2014 as it forms part of UK domestic law by virtue of the European Union (Withdrawal) Act 2018 ("MAR"), and is disclosed in accordance with the company's obligations under Article 17 of MAR.

 

 

Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them

 

1.

Details of the person discharging managerial responsibilities / person closely associated

a)

Name

Paul Swinney

2.

Reason for the Notification.

a)

Position/status

Chief Executive Officer

b)

Initial notification/Amendment

Initial notification

3.

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Tristel plc

b)

LEI

2138009DZ4LH9CZGF662

4.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the Financial instrument, type of instrument

 

Ordinary Shares

Identification code

GB00B07RVT99

b)

Nature of the transaction

Sale of Ordinary Shares

c)

Price(s) and volume(s)

Price

Volume(s)

350 pence

100,000

 

 

 

 

d)

Aggregated information:

- Aggregated volume

- Aggregated price

 

 

 

Single trade as in 4c)

e)

Date of the transaction

27 July 2023

f)

Place of the transaction

London Stock Exchange, AIM Market (XLON)

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DSHZZGZNNRNGFZG
Date   Source Headline
20th Nov 201910:08 amRNSIssue of Equity
18th Nov 20197:00 amRNSUpdate on MobileODT strategic investment
1st Nov 20194:00 pmRNSAudited accounts and notice of AGM
30th Oct 20192:25 pmRNSIssue of Equity
16th Oct 20197:00 amRNSFinal Results
14th Oct 201911:43 amRNSIssue of Equity
13th Sep 20193:58 pmRNSIssue of Equity
10th Sep 201910:27 amRNSHolding(s) in Company
28th Aug 20197:00 amRNSIssue of Equity
21st Aug 20197:00 amRNSInvestor results presentation
7th Aug 201910:31 amRNSIssue of Equity
31st Jul 20193:45 pmRNSHolding(s) in Company
22nd Jul 20197:00 amRNSTrading update, Acquisition & Notice of Results
12th Jun 20197:00 amRNSIssue of Equity
5th Jun 20197:00 amRNSShareholder Open Day
17th May 20191:58 pmRNSIssue of Equity
10th May 201910:26 amRNSHolding(s) in Company
1st Apr 20197:00 amRNSRegulatory approvals in China and South Korea
26th Mar 20197:00 amRNSHolding(s) in Company
6th Mar 20197:00 amRNSIssue of Equity
4th Mar 20192:31 pmRNSIssue of Equity and PDMR Dealing
1st Mar 20193:42 pmRNSDirector/PDMR Shareholding
25th Feb 20197:00 amRNSHalf-year Report
5th Feb 20197:00 amRNSDirector Appointment
14th Jan 20195:26 pmRNSDirector/PDMR Shareholding
14th Jan 201912:00 pmRNSInvestor results presentation
11th Dec 201810:49 amRNSResult of AGM
11th Dec 20187:00 amRNSAGM Statement and notice of results
19th Nov 201811:31 amRNSDirector/PDMR Shareholding
19th Nov 20187:00 amRNSAcquisition & Board Appointment
5th Nov 20188:35 amRNSIssue of Equity
17th Oct 20187:00 amRNSFinal Results
13th Sep 20187:00 amRNSNotice of Results
24th Aug 20187:00 amRNSIssue of Equity
23rd Aug 20187:00 amRNSIssue of Equity
19th Jul 20184:21 pmRNSHolding(s) in Company
19th Jul 20183:55 pmRNSHolding(s) in Company
16th Jul 20185:49 pmRNSResult of secondary placing
16th Jul 20181:53 pmRNSProposed secondary placing of Ordinary Shares
13th Jul 20187:00 amRNSTrading update & Notice of results
12th Jun 20184:39 pmRNSIssue of Equity
11th Jun 20182:37 pmRNSDirector/PDMR Shareholding
8th Jun 20187:00 amRNSShareholder Open Day
7th Jun 20188:15 amRNSIssue of Equity
1st Jun 20183:50 pmRNSDirector/PDMR Shareholdings
15th May 20188:14 amRNSHolding(s) in Company
11th May 20185:45 pmRNSDirector/PDMR Shareholding
10th May 20188:26 amRNSHolding(s) in Company
8th May 20189:51 amRNSIssue of Equity
2nd May 20184:55 pmRNSDirector/PDMR Dealing and Issue of Equity

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.